Design of Pathways for Biofabrication of Global Health Drugs
Linda Broadbelt and Keith Tyo of Northwestern University in the U.S. propose to use a computer-aided design (CAD) tool to identify new metabolic mechanisms of action in priority drugs for the developing world. Understanding of these pathways could help optimize methods to produce low-cost versions of these therapeutics in microbes.